Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.

about

Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.

P2860

Q55347991-A66BE2D1-6DE8-4A6F-BEB8-8A306CA2C823

P2860

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q36484581

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Randomised phase II trial of i ...... isease small-cell lung cancer.

@ast

Randomised phase II trial of i ...... isease small-cell lung cancer.

@en

type

Item

label

Randomised phase II trial of i ...... isease small-cell lung cancer.

@ast

Randomised phase II trial of i ...... isease small-cell lung cancer.

@en

prefLabel

Randomised phase II trial of i ...... isease small-cell lung cancer.

@ast

Randomised phase II trial of i ...... isease small-cell lung cancer.

@en

P1476

Randomised phase II trial of i ...... isease small-cell lung cancer.

@en

P2093

H Isobe

http://www.w3.org/2001/XMLSchema#string

H Nokihara

http://www.w3.org/2001/XMLSchema#string

I Sekine

http://www.w3.org/2001/XMLSchema#string

K Matsui

http://www.w3.org/2001/XMLSchema#string

K Mori

http://www.w3.org/2001/XMLSchema#string

K Nakagawa

http://www.w3.org/2001/XMLSchema#string

K Takeda

http://www.w3.org/2001/XMLSchema#string

N Saijo

http://www.w3.org/2001/XMLSchema#string

T Tamura

http://www.w3.org/2001/XMLSchema#string

Y Nishiwaki

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.

Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI).

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

Selection designs for pilot studies based on survival.

Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer.

P2888

sj.bjc.6604233

P304

693-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604233

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5599388

http://www.w3.org/2001/XMLSchema#string

P698

18253118

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

2259188

http://www.w3.org/2001/XMLSchema#string

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.

about

P2860

P2860

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932